Status:
UNKNOWN
Oral Bacterial and Viral Mapping by Dental Plaque in Elderly Patients With and Without Alzheimer's Disease(ORal MICrobiology in Alzheimer's Patients)
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Periodontitis
Alzheimer Disease
Eligibility:
All Genders
70+ years
Brief Summary
The neurological disorders that accompany aging represent a major public health problem. The management of these diseases is a major medical and social priority. This project is based on the assumptio...
Eligibility Criteria
Inclusion
- Age greater than or equal to 70 years old
- Patient (or trusted person) having read and understood the study information note and signed the informed consent form
- Membership in a social security scheme
- For cases : Diagnosis of possible or probable Alzheimer's disease according to the DSM-V
Exclusion
- Presence of a neurodegenerative pathology (excluding Alzheimer's disease for cases)
- Presence of a neurocognitive disorder (excluding Alzheimer's disease for the cases)
- Patient with or having had any kind of cancer, including oral or aerodigestive tract
- Patients with or having had autoimmune diseases (HIV, hepatitis)
- Patients with inflammatory diseases (such as rheumatoid arthritis (RA) or Gougerot-Sjogren's syndrome (GSJ))
- Patients with severe haemopathy
- Patients with severe acute or chronic cardiovascular, renal, hepatic, gastrointestinal, allergic, endocrine, pulmonary, neuropsychiatric pathologies, judged by the investigator to be incompatible with the study, as all these pathologies may interfere with the results of the oral flora sampling
- Patients who have undergone oral surgery in the two months prior to sampling
- Patients treated with oral retinoids, bisphosphonates, oral anticoagulants or anticonvulsants
- Patients who have had anti-cancer or immunosuppressive chemotherapy within the last 6 months
- Patient who has had antibiotic or anti-inflammatory treatment in the last 4 weeks
- A history of treatments (drugs and probiotics) taken in the month prior to sampling will be taken, as well as a record of toxic habits (tobacco, alcohol, other)
Key Trial Info
Start Date :
June 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04869904
Start Date
June 1 2021
End Date
December 31 2021
Last Update
May 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nice University Hospital
Nice, France, 06000